Tools

LEADER 03269nam a22005538i 4500

001 ssj0002701342;

003 WaSeSS;

005 20251212090320.0;

006 m d ;

007 cr n ;

008 220720s2022 flu sb 001 0 eng d;

010 a| 2022026804;

020 a| 9780367861599q| (hardback);

020 a| 9781032374086q| (paperback);

020 z| 9781003017288q| (ebook);

035 a| (WaSeSS)ssj0002701342;

040 a| DNLM/DLCb| engc| DLCd| WaSeSS;

042 a| pcc;

049 a| EREEa| NEHH;

050 00 a| R853.C55;

060 00 a| W 83.1;

082 00 a| 615.502852| 23/eng/20221128;

245 00 a| Digital therapeuticsh| [electronic resource] :b| strategic, scientific, developmental, and regulatory aspects /c| edited by Oleksandr Sverdlov and Joris van Dam.;

250 a| First edition.;

260 a| Boca Raton :b| CRC Press,c| 2022.;

263 a| 2212;

300 a| pages cm;

490 0 a| Chapman & Hall/CRC biostatistics series;

504 a| Includes bibliographical references and index.;

506 a| Available only to authorized users.;

520 a| "One of the hallmarks of the 21st century medicine is the emergence of digital therapeutics (DTx)-evidence-based, clinically validated digital technologies to prevent, diagnose, treat, and manage various diseases and medical conditions. DTx solutions have been gaining interest from patients, investors, healthcare providers, health authorities, and other stakeholders because of the potential of DTx to deliver equitable, massively scalable, personalized and transformative treatments for different unmet medical needs. Digital Therapeutics: Scientific, Statistical, Clinical, and Regulatory Aspects is an unparalleled summary of the current scientific, statistical, developmental, and regulatory aspects of DTx which is poised to become the fastest growing area of the biopharmaceutical and digital medicine product development. This edited volume intends to provide a systematic exposition to digital therapeutics through 19 peer-reviewed chapters written by subject matter experts in this emerging field"--c| Provided by publisher.;

538 a| Mode of access: World Wide Web;

650 12 a| Therapeutics=| ^A934229;

650 12 a| Digital Technology=| ^A1462486;

650 22 a| Telemedicine=| ^A930978;

650 22 a| Clinical Trials as Topic=| ^A920927;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Sverdlov, Oleksandr.?| UNAUTHORIZED;

700 1 a| Dam, Joris van.?| UNAUTHORIZED;

830 0 a| Chapman & Hall/CRC biostatistics series=| ^A707265;

856 40 z| Full text available from Taylor & Francis eBooksu| https://go.openathens.net/redirector/ecu.edu?url=https%3A%2F%2Fwww.taylorfrancis.com%2Fbooks%2F9781003017288;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 6663907;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6663907-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 12/19/2025x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6663907-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 12/19/2025x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6663907-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 12/19/2025x| EBOOKz| JERESOURCE;

Digital therapeutics strategic, scientific, developmental, and regulatory aspects / edited by Oleksandr Sverdlov and Joris van Dam.

Other author	Sverdlov, Oleksandr.
Other author	Dam, Joris van.
Format	Electronic
Edition	First edition.
Publication Info	Boca Raton : CRC Press, 2022.
Description	pages cm
Supplemental Content	Full text available from Taylor & Francis eBooks
Subjects	Therapeutics Digital Technology Telemedicine Clinical Trials as Topic

Series	Chapman & Hall/CRC biostatistics series Chapman & Hall/CRC biostatistics series ^A707265
Abstract	"One of the hallmarks of the 21st century medicine is the emergence of digital therapeutics (DTx)-evidence-based, clinically validated digital technologies to prevent, diagnose, treat, and manage various diseases and medical conditions. DTx solutions have been gaining interest from patients, investors, healthcare providers, health authorities, and other stakeholders because of the potential of DTx to deliver equitable, massively scalable, personalized and transformative treatments for different unmet medical needs. Digital Therapeutics: Scientific, Statistical, Clinical, and Regulatory Aspects is an unparalleled summary of the current scientific, statistical, developmental, and regulatory aspects of DTx which is poised to become the fastest growing area of the biopharmaceutical and digital medicine product development. This edited volume intends to provide a systematic exposition to digital therapeutics through 19 peer-reviewed chapters written by subject matter experts in this emerging field"-- Provided by publisher.
Bibliography note	Includes bibliographical references and index.
Access restriction	Available only to authorized users.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2022026804
ISBN	9780367861599 (hardback)
ISBN	9781032374086 (paperback)
ISBN	(ebook)

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Digital therapeutics strategic, scientific, developmental, and regulatory aspects / edited by Oleksandr Sverdlov and Joris van Dam.

Click here for more information about this title

Availability